XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Divestiture of Preclinical Small Molecule Programs (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 01, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
May 01, 2024
ft²
extension_option
Disposal Groups, Including Disposal Of Long-Lived Assets [Line Items]            
Equity consideration received in the divestiture of small molecule programs (Note 10)       $ 15,000 $ 0  
Lessor, operating sublease, rentable area | ft²           12,985
Sublease term           10 months
Lessor, operating sublease, number of options to extend | extension_option           2
Sublease renewal option term           6 months
Gain from divestiture of small molecule programs   $ 0 $ 0 14,537 $ 0  
Venture Backed Private Company ("VBPC")            
Disposal Groups, Including Disposal Of Long-Lived Assets [Line Items]            
Equity consideration received in the divestiture of small molecule programs (Note 10) $ 15,000          
Noncash or part noncash divestiture, milestone payments, to be received   $ 1,200,000   $ 1,200,000    
Future royalties, threshold after first commercial sale   10 years   10 years    
Gain from divestiture of small molecule programs       $ 14,500